These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36203656)

  • 1. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
    Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
    Front Public Health; 2022; 10():979933. PubMed ID: 36203656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.
    Zhu X; Li S; Luo J; Ying X; Li Z; Wang Y; Zhang M; Zhang T; Jiang P; Wang X
    Front Immunol; 2022; 13():801639. PubMed ID: 35126391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
    Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
    Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.
    Lu Q; Nie R; Luo J; Wang X; You L
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
    Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
    Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV-driven heterogeneity in cervical cancer: study on the role of epithelial cells and myofibroblasts in the tumor progression based on single-cell RNA sequencing analysis.
    Zhang Y; Zhang Y; Pan C; Wang W; Yu Y
    PeerJ; 2024; 12():e18158. PubMed ID: 39346086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
    Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
    Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Single-Cell RNA-Seq and Bulk RNA-Seq to Construct a Novel γδT Cell-Related Prognostic Signature for Human Papillomavirus-Infected Cervical Cancer.
    Wang X; Jin Y; Xu L; Tao S; Wu Y; Ao C
    Cancer Control; 2024; 31():10732748241274228. PubMed ID: 39206965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological classification of hepatitis B virus-positive hepatocellular carcinoma by transcriptome analysis.
    Li SW; Han LF; He Y; Wang XS
    World J Hepatol; 2022 Dec; 14(12):1997-2011. PubMed ID: 36618328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtyping of head and neck squamous cell cancers based on immune signatures.
    Song D; Lyu H; Feng Q; Luo J; Li L; Wang X
    Int Immunopharmacol; 2021 Oct; 99():108007. PubMed ID: 34332341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-region sequencing depicts intratumor heterogeneity and clonal evolution in cervical cancer.
    Wang C; Bai R; Liu Y; Wang K; Wang Y; Yang J; Cai H; Yang P
    Med Oncol; 2023 Jan; 40(2):78. PubMed ID: 36635412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA-sequencing dissects cellular heterogeneity and identifies two tumor-suppressing immune cell subclusters in HPV-related cervical adenosquamous carcinoma.
    Li X; Zhang M; Lei T; Zou W; Huang R; Wang F; Huang Q; Wang C; Liu C
    J Med Virol; 2022 Dec; 94(12):6047-6059. PubMed ID: 36000446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
    Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HPV16 positive cervical cancer subsets characterized by divergent immune and oncogenic phenotypes with potential implications for immunotherapy.
    Ghosh A; Ghosh A; Sinha A; Mathai S; Bhaumik J; Mukhopadhyay A; Maitra A; Biswas NK; Majumder PP; Sengupta S
    Tumour Biol; 2023; 45(1):55-69. PubMed ID: 37599552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy.
    Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN
    Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma.
    Liu Q; Nie R; Li M; Li L; Zhou H; Lu H; Wang X
    Comput Struct Biotechnol J; 2021; 19():4472-4485. PubMed ID: 34471493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes.
    Yao J; Li S; Wang X
    Front Cell Dev Biol; 2021; 9():781848. PubMed ID: 35047498
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of the Toll-Like Receptor/Nitric Oxide Signaling Pathway in the Pathogenesis of Cervical Cancer Caused by High-Risk Human Papillomavirus Infection.
    Li J; Rao H; Jin C; Liu J
    Biomed Res Int; 2017; 2017():7830262. PubMed ID: 28626766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Wang Y; He M; He T; Ouyang X; Shen X; Shi W; Huang S; Xiang L; Zou D; Jiang W; Yang H
    Br J Cancer; 2024 Apr; 130(6):987-1000. PubMed ID: 38253702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.